[Alpha- methyl-P-tyrosine effect in extrapyramidal diseases].
D002395:Catecholamines / Q000096:biosynthesis; D002819:Chorea / Q000188:drug therapy*; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D008781:Methyltyrosines / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy
D002395:Catecholamines; D008781:Methyltyrosines
Der alpha-Methyl-P-Tyrosin-Effekt bei extrapyramidalen Erkrankungen.